000 | 01997 a2200613 4500 | ||
---|---|---|---|
005 | 20250515035032.0 | ||
264 | 0 | _c20070201 | |
008 | 200702s 0 0 eng d | ||
022 | _a0017-5749 | ||
024 | 7 |
_a10.1136/gut.2005.083477 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPéron, J M | |
245 | 0 | 0 |
_aTreatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity. _h[electronic resource] |
260 |
_bGut _cJan 2007 |
||
300 |
_a107-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _ximmunology |
650 | 0 | 4 |
_aCell Division _ximmunology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblasts _ximmunology |
650 | 0 | 4 |
_aFlow Cytometry _xmethods |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 |
_aImmunity, Innate _ximmunology |
650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 |
_aInterleukin-12 _xadministration & dosage |
650 | 0 | 4 |
_aMacrophages _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aPancreatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xgenetics |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
700 | 1 | _aBureau, C | |
700 | 1 | _aGourdy, P | |
700 | 1 | _aLulka, H | |
700 | 1 | _aSouque, A | |
700 | 1 | _aCalippe, B | |
700 | 1 | _aSelves, J | |
700 | 1 | _aAl Saati, T | |
700 | 1 | _aBernad, J | |
700 | 1 | _aCordelier, P | |
700 | 1 | _aCouderc, B | |
700 | 1 | _aPradayrol, L | |
700 | 1 | _aPipy, B | |
700 | 1 | _aBuscail, L | |
700 | 1 | _aVinel, J P | |
773 | 0 |
_tGut _gvol. 56 _gno. 1 _gp. 107-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2005.083477 _zAvailable from publisher's website |
999 |
_c16479547 _d16479547 |